After testing the blinded samples, the DiagMMR test results were compared with the available clinical data, which revealed that in cases where tumor tissue had shown MSH2 and/or MSH6 protein expression loss with IHC, an MMR gene variant was found in only one case, and here it is pathogenicity could not be confirmed (Table 2). This evidence concerns the gene MRC1 and neoplasm.